Geoff MacKay is President and Chief Executive Officer of Organogenesis Inc., a leading cell therapy company.  Mr MacKay comes from Novartis AG where he was Vice-President & Business Unit Head, Transplantation & Immunology in Canada.   Prior to that, Mr MacKay served as Vice-President of Tissue-Engineering in Novartis USA.    Mr MacKay provides Organogenesis with broad commercial experience, having also worked as Novartis Head of Global Sales Immunology & Transplantation in Basel, Switzerland, and prior to that as Sales & Marketing Manager of Novartis Biotech Europe. 

Mr MacKay serves as Vice-chairman of the board of MassBio and is on the board of the Canadian Stem Cell Network, the Western University School of Podiatric Medicine Dean’s Advisory Council, and The editorial board of the journal “Regenerative Medicine”.